Evaluating iatrogenic prescribing: Development of an oncology-focused trigger tool (Englisch)
- Neue Suche nach: Hebert, G.
- Neue Suche nach: Netzer, F.
- Neue Suche nach: Ferrua, M.
- Neue Suche nach: Ducreux, M.
- Neue Suche nach: Lemare, F.
- Neue Suche nach: Minvielle, E.
- Neue Suche nach: Hebert, G.
- Neue Suche nach: Netzer, F.
- Neue Suche nach: Ferrua, M.
- Neue Suche nach: Ducreux, M.
- Neue Suche nach: Lemare, F.
- Neue Suche nach: Minvielle, E.
In:
EUROPEAN JOURNAL OF CANCER -A-
;
51
, 3
;
427-435
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Evaluating iatrogenic prescribing: Development of an oncology-focused trigger tool
-
Beteiligte:Hebert, G. ( Autor:in ) / Netzer, F. ( Autor:in ) / Ferrua, M. ( Autor:in ) / Ducreux, M. ( Autor:in ) / Lemare, F. ( Autor:in ) / Minvielle, E. ( Autor:in )
-
Erschienen in:EUROPEAN JOURNAL OF CANCER -A- ; 51, 3 ; 427-435
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:9 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 51, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 271
-
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers InitiativeBogaerts, J. / Sydes, M.R. / Keat, N. / McConnell, A. / Benson, A. / Ho, A. / Roth, A. / Fortpied, C. / Eng, C. et al. | 2015
- 282
-
Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohortVos, E.L. / Jager, A. / Verhoef, C. / Voogd, A.C. / Koppert, L.B. et al. | 2015
- 292
-
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivorsEckhoff, L. / Knoop, AS. / Jensen, MB. / Ewertz, M. et al. | 2015
- 301
-
Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994BIG 1-00 phase III trialFei, F. / Messina, C. / Slaets, L. / Chakiba, C. / Cameron, D. / Bogaerts, J. / Bonnefoi, H. et al. | 2015
- 310
-
Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies - A population-based studyde Glas, N.A. / Bastiaannet, E. / de Craen, A.J.M. / van de Velde, C.J.H. / Siesling, S. / Liefers, G.J. / Portielje, J.E.A. et al. | 2015
- 317
-
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancerLUME-Lung 1 Study Group / Novello, S. / Kaiser, R. / Mellemgaard, A. / Douillard, J.Y. / Orlov, S. / Krzakowski, M. / von Pawel, J. / Gottfried, M. et al. | 2015
- 327
-
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizonsHollebecque, A. / Malka, D. / Ferte, C. / Ducreux, M. / Boige, V. et al. | 2015
- 340
-
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumourSatoh, T. / Aoki, Y. / Kasamatsu, T. / Ochiai, K. / Takano, M. / Watanabe, Y. / Kikkawa, F. / Takeshima, N. / Hatae, M. et al. | 2015
- 352
-
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trialMahner, S. / Meier, W. / du Bois, A. / Brown, C. / Lorusso, D. / Dell'Anna, T. / Cretin, J. / Havsteen, H. / Bessette, P. et al. | 2015
- 359
-
PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxelCoupe, N. / Corrie, P. / Hategan, M. / Larkin, J. / Gore, M. / Gupta, A. / Wise, A. / Suter, S. / Ciria, C. et al. | 2015
- 367
-
Treatment modifications in tumour necrosis factor-@a (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomasDeroose, J.P. / Grunhagen, D.J. / de Wilt, J.H.W. / Eggermont, A.M.M. / Verhoef, C. et al. | 2015
- 374
-
Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyFrezza, A.M. / Cesari, M. / Baumhoer, D. / Biau, D. / Bielack, S. / Campanacci, D.A. / Casanova, J. / Esler, C. / Ferrari, S. et al. | 2015
- 382
-
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patientsRoth, P. / Keller, A. / Hoheisel, J.D. / Codo, P. / Bauer, A.S. / Backes, C. / Leidinger, P. / Meese, E. / Thiel, E. et al. | 2015
- 391
-
Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: A prospected population based study in the south of The NetherlandsKlompenhouwer, E.G. / Voogd, A.C. / den Heeten, G.J. / Strobbe, L.J.A. / de Haan, A.F.J. / Wauters, C.A. / Broeders, M.J.M. / Duijm, L.E.M. et al. | 2015
- 400
-
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancerFakkert, I.E. / Abma, E.M. / Westrik, I.G. / Lefrandt, J.D. / Wolffenbuttel, B.H.R. / Oosterwijk, J.C. / Slart, R.H.J.A. / van der Veer, E. / de Bock, G.H. et al. | 2015
- 409
-
MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomasGattolliat, C.H. / Uguen, A. / Pesson, M. / Trillet, K. / Simon, B. / Doucet, L. / Robaszkiewicz, M. / Corcos, L. et al. | 2015
- 421
-
PD-L1 expression in small cell neuroendocrine carcinomasSchultheis, A.M. / Scheel, A.H. / Ozretic, L. / George, J. / Thomas, R.K. / Hagemann, T. / Zander, T. / Wolf, J. / Buettner, R. et al. | 2015
- 427
-
Evaluating iatrogenic prescribing: Development of an oncology-focused trigger toolHebert, G. / Netzer, F. / Ferrua, M. / Ducreux, M. / Lemare, F. / Minvielle, E. et al. | 2015